Hubei Biocause Heilen Pharmaceutical Co., Ltd.
public_traded
Hubei Biocause Heilen Pharmaceutical Co., Ltd. is publicly traded on SHZ under ticker 301211.SZ.
Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China. It provides APIs and intermediates, and formulations; and dimethyl ether gas and chloropropionyl chloride chemical products. The company is based in Jingmen, China.